Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)β’ Click on a phase to view related trials
Extension Study of ABP-671 in Participants With Gout
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-07-16
- Target Recruit Count
- 580
- Registration Number
- NCT06276556
- Locations
- πΊπΈ
Alliance for Multispecialty Research, Tempe, Arizona, United States
πΊπΈTucson Neuroscience Research, LLC, Tucson, Arizona, United States
πΊπΈAnaheim Clinical Trials (Cenexel ACT), Anaheim, California, United States
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Atom Therapeutics Co., Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT06258213
- Locations
- πΊπΈ
Worldwide Clinical Trials, San Antonio, Texas, United States
Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
- Conditions
- Gout
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-08-15
- Target Recruit Count
- 580
- Registration Number
- NCT05818085
- Locations
- πΊπΈ
Alliance for Multispecialty Research, Tempe, Arizona, United States
πΊπΈTucson Neuroscience Research, LLC, Tucson, Arizona, United States
πΊπΈAnaheim Clinical Trials (Cenexel ACT), Anaheim, California, United States
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia
- First Posted Date
- 2020-11-20
- Last Posted Date
- 2023-04-12
- Target Recruit Count
- 60
- Registration Number
- NCT04638543
- Locations
- π¦πΊ
Paratus - Canberra Clinic, Canberra, Australia
π¦πΊParatus - Central Coast Clinic, Kanwal, Australia
π¦πΊPeninsula Private Hospital, Kippa-Ring, Australia
Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2020-06-23
- Target Recruit Count
- 12
- Registration Number
- NCT04303039
- Locations
- πΊπΈ
Pharmaron CPC, Inc., Baltimore, Maryland, United States
- Prev
- 1
- 2
- Next